Suppr超能文献

星形胶质细胞在多发性硬化症中的作用调控。

Regulation of Astrocyte Functions in Multiple Sclerosis.

机构信息

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.

The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142.

出版信息

Cold Spring Harb Perspect Med. 2019 Jan 2;9(1):a029009. doi: 10.1101/cshperspect.a029009.

Abstract

Astrocytes play complex roles in health and disease. Here, we review recent findings on molecular pathways that control astrocyte function in multiple sclerosis (MS) as well as new tools for their investigation. In particular, we describe positive and negative regulators of astrocyte-mediated pathogenesis in MS, such as sphingolipid metabolism and aryl hydrocarbon receptor signaling, respectively. In addition, we also discuss the issue of astrocyte heterogeneity and its relevance for the contribution of astrocytes to MS pathogenesis. Finally, we discuss how new genomic tools could transform the study of astrocyte biology in MS.

摘要

星形胶质细胞在健康和疾病中发挥着复杂的作用。在这里,我们回顾了控制多发性硬化症(MS)中星形胶质细胞功能的分子途径的最新发现,以及用于研究这些途径的新工具。特别是,我们分别描述了鞘脂代谢和芳基烃受体信号传导等分别控制 MS 中星形胶质细胞介导的发病机制的正调节剂和负调节剂。此外,我们还讨论了星形胶质细胞异质性及其与星形胶质细胞对 MS 发病机制的贡献的相关性的问题。最后,我们讨论了新的基因组工具如何改变 MS 中星形胶质细胞生物学的研究。

相似文献

1
Regulation of Astrocyte Functions in Multiple Sclerosis.
Cold Spring Harb Perspect Med. 2019 Jan 2;9(1):a029009. doi: 10.1101/cshperspect.a029009.
2
Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
J Immunol. 2010 Nov 15;185(10):5693-703. doi: 10.4049/jimmunol.1002188. Epub 2010 Oct 6.
3
Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
Brain Behav Immun. 2015 Aug;48:313-25. doi: 10.1016/j.bbi.2015.04.013. Epub 2015 Apr 30.
4
The Role of Astrocytes in Multiple Sclerosis.
Front Immunol. 2018 Feb 19;9:217. doi: 10.3389/fimmu.2018.00217. eCollection 2018.
5
Astrocytes in multiple sclerosis: a product of their environment.
Cell Mol Life Sci. 2008 Sep;65(17):2702-20. doi: 10.1007/s00018-008-8059-5.
8
Control of autoimmune CNS inflammation by astrocytes.
Semin Immunopathol. 2015 Nov;37(6):625-38. doi: 10.1007/s00281-015-0515-3. Epub 2015 Jul 30.
9
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Ann Neurol. 2014 Sep;76(3):325-37. doi: 10.1002/ana.24217. Epub 2014 Jul 15.
10
A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.
Ann Neurol. 2019 Mar;85(3):406-420. doi: 10.1002/ana.25415. Epub 2019 Feb 4.

引用本文的文献

2
3
4
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model.
Nat Neurosci. 2025 Mar;28(3):470-486. doi: 10.1038/s41593-025-01875-9. Epub 2025 Mar 3.
6
Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer's disease progression.
Front Cell Neurosci. 2025 Jan 6;18:1512985. doi: 10.3389/fncel.2024.1512985. eCollection 2024.
7
Characteristics of the Dynamic Evolutionary Pathway of ADSCs Induced Differentiation into Astrocytes Based on scRNA-Seq Analysis.
Mol Neurobiol. 2025 Mar;62(3):2926-2944. doi: 10.1007/s12035-024-04414-y. Epub 2024 Aug 27.
8
Glycolytic dysregulation in Alzheimer's disease: unveiling new avenues for understanding pathogenesis and improving therapy.
Neural Regen Res. 2025 Aug 1;20(8):2264-2278. doi: 10.4103/NRR.NRR-D-24-00190. Epub 2024 Jul 29.
9
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes.
Cells. 2024 May 27;13(11):921. doi: 10.3390/cells13110921.
10
The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
PLoS One. 2024 Apr 2;19(4):e0300203. doi: 10.1371/journal.pone.0300203. eCollection 2024.

本文引用的文献

1
Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS.
Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e359. doi: 10.1212/NXI.0000000000000359. eCollection 2017 Jul.
2
Role of AHR and HIF-1α in Glioblastoma Metabolism.
Trends Endocrinol Metab. 2017 Jun;28(6):428-436. doi: 10.1016/j.tem.2017.02.009. Epub 2017 Mar 16.
3
Astrocytes Control Circadian Timekeeping in the Suprachiasmatic Nucleus via Glutamatergic Signaling.
Neuron. 2017 Mar 22;93(6):1420-1435.e5. doi: 10.1016/j.neuron.2017.02.030. Epub 2017 Mar 9.
4
Laquinimod enhances central nervous system barrier functions.
Neurobiol Dis. 2017 Jun;102:60-69. doi: 10.1016/j.nbd.2017.02.002. Epub 2017 Feb 22.
5
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2012-2017. doi: 10.1073/pnas.1615413114. Epub 2017 Feb 6.
6
Identification of diverse astrocyte populations and their malignant analogs.
Nat Neurosci. 2017 Mar;20(3):396-405. doi: 10.1038/nn.4493. Epub 2017 Feb 6.
7
Neurotoxic reactive astrocytes are induced by activated microglia.
Nature. 2017 Jan 26;541(7638):481-487. doi: 10.1038/nature21029. Epub 2017 Jan 18.
8
Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
PLoS One. 2016 Dec 9;11(12):e0165118. doi: 10.1371/journal.pone.0165118. eCollection 2016.
9
Functional diversity of astrocytes in neural circuit regulation.
Nat Rev Neurosci. 2017 Jan;18(1):31-41. doi: 10.1038/nrn.2016.159. Epub 2016 Dec 1.
10
Neuromodulators signal through astrocytes to alter neural circuit activity and behaviour.
Nature. 2016 Nov 17;539(7629):428-432. doi: 10.1038/nature20145. Epub 2016 Nov 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验